Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

Endothelial tyrosine kinase Tie2 counteracts atherosclerosis development

We report an intronic variant of the endothelial angiopoietin receptor TIE2 that is associated with increased gene expression and decreased risk of coronary artery disease. Genetic deletion of Tie2 in hypercholesterolemic mice shows that the Tie2 receptor protects from atherosclerosis by controlling inflammation in the arterial wall.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Tie2 is atheroprotective.

References

  1. Sack, K. D., Kellum, J. A. & Parikh, S. M. The angiopoietin-Tie2 pathway in critical illness. Crit. Care Clin. 36, 201–216 (2020). A review of the importance of Angpt–Tie in patients who are critically ill.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Saharinen, P., Eklund, L. & Alitalo, K. Therapeutic targeting of the angiopoietin-TIE pathway. Nat. Rev. Drug Discov. 16, 635–661 (2017). A review article that presents the druggability of the Angpt–Tie signaling pathway.

    Article  CAS  PubMed  Google Scholar 

  3. Porat, R. M. et al. Specific induction of tie1 promoter by disturbed flow in atherosclerosis-prone vascular niches and flow-obstructing pathologies. Circ. Res. 94, 394–401 (2004). This paper shows that disturbed blood flow increases Tie1 expression.

    Article  CAS  PubMed  Google Scholar 

  4. Woo, K. V. et al. Tie1 attenuation reduces murine atherosclerosis in a dose-dependent and shear stress-specific manner. J. Clin. Invest. 121, 1624–1635 (2011). This paper shows that Tie1 attenuation reduces atherosclerosis in Apoe-/- mice.

  5. Theelen, T. L. et al. Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice. Atherosclerosis 241, 297–304 (2015). This paper shows that Angpt2-blocking antibodies reduce atherosclerosis in mice.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ahmed, A. et al. Angiopoietin-2 confers atheroprotection in apoE-/- mice by inhibiting LDL oxidation via nitric oxide. Circ. Res. 104, 1333–1336 (2009). This paper reports that systemic levels of Angpt2 are atheroprotective.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Anisimov, A. et al. The angiopoietin receptor TIE2 is atheroprotective in arterial endothelium. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-023-00224-y (2023).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Endothelial tyrosine kinase Tie2 counteracts atherosclerosis development. Nat Cardiovasc Res 2, 232–233 (2023). https://doi.org/10.1038/s44161-023-00251-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44161-023-00251-9

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing